In the past two years, no topic has been discussed more than COVID-19, and its findings remain hot. Even today, 23% of adults are apprehensive about the coronavirus, according to a recent survey. Fortunately, the crisis has spurred exciting innovations, from diagnosis to treatment, from vaccines to telemedicine. Today, 36% of US adults use telemedicine, up from 13% in April 2020, and nothing beats laboratory automation. Lab automation uses sophisticated laboratory information and automated laboratory tools from management systems to generate accurate test results at any scale. These smart lab instruments use embedded processors to control robots, support Internet of Things (IoT) technologies, and perform sophisticated analytics.

The global laboratory automation market size with proven processes and performance at an unprecedented time in the global healthcare sector is expected to grow from around $4.3 billion in 2020 to $5.5 billion in 2025, at a CAGR of 5.2% during the forecast period.

For more information on this topic, attend the Virtual Summit on the Future of Lab Automation for Businesses, hosted by Group Futurista. An informative webinar with snippets, narration, and a selection of outstanding speakers that will come together to share their thoughts on the future of central nodes.